Norovirus P particle, a novel platform for vaccine development and antibody production. - Wikidata - wikimedia - TriplyDB

Norovirus P particle, a novel platform for vaccine development and antibody production.

Norovirus P particle, a novel platform for vaccine development and antibody production.

http://www.wikidata.org/entity/Q34485266

about

Immunogenetic mechanisms driving norovirus GII.4 antigenic variation Tropical and travel-associated norovirus: current concepts Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae Crystallography of a Lewis-Binding Norovirus, Elucidation of Strain-Specificity to the Polymorphic Human Histo-Blood Group Antigens Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assay Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy.Antibodies against Lewis antigens inhibit the binding of human norovirus GII.4 virus-like particles to saliva but not to intestinal Caco-2 cells Vaccine against norovirus.Subviral particle as vaccine and vaccine platform.Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.Branched-linear and agglomerate protein polymers as vaccine platforms.Affinities of recombinant norovirus P dimers for human blood group antigens Norovirus P particle efficiently elicits innate, humoral and cellular immunity Isolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens.Identifying carbohydrate ligands of a norovirus P particle using a catch and release electrospray ionization mass spectrometry assay.Energetic changes caused by antigenic module insertion in a virus-like particle revealed by experiment and molecular dynamics simulations.A candidate dual vaccine against influenza and noroviruses.Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner.Complicated norovirus infection and assessment of severity by a modified Vesikari disease score system in hospitalized children.Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens.Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives Engineering Bacterial Surface Displayed Human Norovirus Capsid Proteins: A Novel System to Explore Interaction Between Norovirus and Ligands.Evaluation of anti-norovirus IgY from egg yolk of chickens immunized with norovirus P particles Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus.Polyvalent complexes for vaccine development Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus.Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.Norovirus vaccines: Correlates of protection, challenges and limitations Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses.A dual vaccine candidate against norovirus and hepatitis E virus.A dual chicken IgY against rotavirus and norovirus.Recent advancements in combination subunit vaccine development.Production of Brazilian human norovirus VLPs and comparison of purification methods.Characterization of the new GII.17 norovirus variant that emerged recently as the predominant strain in China.Structural Evolution of the Emerging 2014-2015 GII.17 Noroviruses.Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.Prospects and Challenges in the Development of a Norovirus Vaccine.Molecular analysis of norovirus in specimens from children enrolled in a 1982-1986 study in Belém, Brazil: A community-based longitudinal study.

P2860

Q24810360-A00B184B-E8BF-4758-8235-D25640D2CDD0 Q26799737-16557448-B607-4D5D-94AB-CF0E1153BEF0 Q27004488-71FD8DA6-43AD-46A3-A1B7-AE4ACD41AE49 Q27671411-A2B003A7-E976-426A-9B39-7DB0F4900DFC Q28477791-8DC79984-EDA4-4321-8255-24C1EF13F2D4 Q30234848-F2AC01E7-A20F-456F-B002-EAAC2C617C83 Q30388370-E00F3E56-EDFA-4601-98AE-01229CFDCDDC Q33578075-BCC48F9E-6395-4C24-B49E-AEF5C7DD74E9 Q33812653-13EFB93F-4917-4085-B42F-C549FE94AE53 Q34059409-115678DF-CF55-40F2-B895-3BBC2128301F Q34064413-8B70C931-4162-4F7D-9088-A65A3C35A368 Q34464196-B2B6418C-8AC9-4B58-8B46-832D9E76D076 Q34702360-3403331C-A858-47C9-A5E4-FD16C76DA4DB Q34985473-1CE8CAF7-DDCD-4726-85FA-25183BF59250 Q35008592-04A9499E-0E62-4A85-92BD-3BAAFA4B57B9 Q35250141-D1214350-B389-472F-A569-53D32D8DF6D3 Q35301295-AC40B3EE-4761-4DEF-9CE5-A3391A00C407 Q35943850-830D74BA-0FF2-41BA-A3D8-D30EC2030107 Q36157186-C1ED30D9-C518-462B-89D8-627038A9DFAB Q36210208-FE0DEEC3-28A1-412F-A2E2-499E4FCAF675 Q36267431-EFCCF587-240C-43D8-9286-4A3707251715 Q36275589-0DF8AF75-3403-4D8B-9B90-13E68B37EC24 Q36391936-9DD725BF-0F5D-42C2-BBF4-7085B4F324F1 Q36392947-7836AFB1-ECA1-4DBB-B04F-1F318F3C37D2 Q36445296-D32398D5-BC51-44EF-91B7-CE9EBBCB56AA Q36519453-DF0AE0C2-59CF-49E5-A874-D3D4F6567AD0 Q36792270-284F9A32-A4A8-4B8C-856A-675C0990A1CA Q36914794-4EFD153B-2A10-4403-A0DC-086EBCA90B48 Q36970026-5A407C5D-4A43-4D3B-B597-877A0E169527 Q37135476-E1F4CD25-CB05-45E2-8A6D-CA0F6F9F770D Q37195802-D7AC86E8-14C3-4E3D-A69D-94164C40FE36 Q37502688-2DB4EDA7-944A-4276-A73E-FD8E95823E32 Q37716268-F323258A-B421-487D-BA3F-2896742A9903 Q38819439-174B68C2-0520-4C86-BF8F-B596148F617D Q38929391-1E33E562-1B6F-4DF8-9950-63C2DF08DA17 Q39471943-D44D20D6-CF08-4D0B-8A51-87F553634F15 Q39604515-A1B46A0D-A2D0-452B-A581-DAC1E0740881 Q40044140-EA625D31-FEC7-4631-AB4C-167BBF22ABE9 Q40102851-511B59FD-8BD4-4E5B-B27C-0B348E667AC9 Q40261280-657FF4FE-6AFC-4D82-8684-5FE54796DE4C

P2860

Norovirus P particle, a novel platform for vaccine development and antibody production.

http://www.wikidata.org/entity/Q34485266

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Norovirus P particle, a novel platform for vaccine development and antibody production.

@ast

Norovirus P particle, a novel platform for vaccine development and antibody production.

@en

Norovirus P particle, a novel platform for vaccine development and antibody production.

@nl

type

label

Norovirus P particle, a novel platform for vaccine development and antibody production.

@ast

Norovirus P particle, a novel platform for vaccine development and antibody production.

@en

Norovirus P particle, a novel platform for vaccine development and antibody production.

@nl

prefLabel

Norovirus P particle, a novel platform for vaccine development and antibody production.

@ast

Norovirus P particle, a novel platform for vaccine development and antibody production.

@en

Norovirus P particle, a novel platform for vaccine development and antibody production.

@nl

P1433

Q34485266-06270FE3-9D98-4278-A948-F02ADF95D077

P1476

Q34485266-02F8BB33-7EAA-49DF-9DBB-FF8C0761753B

P2093

Q34485266-147586C1-9721-4B4A-BC6E-7565216F1342

Q34485266-24CA936B-A0BD-40B5-8C01-2684695FAEF9

Q34485266-4FC184AB-90A1-421A-9FCC-73AB2BC0E79E

Q34485266-9ECDCD7D-17AF-498D-8B8D-6339B2BD474B

Q34485266-C70BE5FD-4221-4893-8930-C7D2CFC7B497

Q34485266-E149131B-328E-4796-878E-DFAA9FE578C8

Q34485266-EA668BFE-41BB-466C-98D8-16F5207FF674

Q34485266-EB77034F-3F64-4A54-9860-70C40DB3826A

Q34485266-F7D2E0B1-8DD1-47BF-BB0A-DBE367CA745D

P2860

Q34485266-0DF5C290-4B58-40BF-BC5B-CE2DD964F88D

Q34485266-0FCDB351-F891-4067-A86E-D00A971AB99B

Q34485266-1FB61051-1EE0-40C2-B8CB-7030168B1E10

Q34485266-24DAB4A2-8332-44EE-9A0D-73B197BDC842

Q34485266-26545A2F-1D6A-4259-9260-D5963447CB4D

Q34485266-2EF8828E-EDD2-46C2-B32D-BF2FB736F89E

Q34485266-3E401EE2-45C4-4CFA-B369-ABBA34E45591

Q34485266-596CD658-AC5B-45C5-A27F-11D721AE113F

Q34485266-59855FBF-399D-4F15-8EFB-DC3782290BE4

Q34485266-5A13F84E-6935-468B-B770-C23CF6250234

P304

Q34485266-F9AD3852-0DB9-4CEA-8983-D75FC76A2775

P31

Q34485266-65222892-468D-4D65-9AA4-EE2655EEEA6C

P356

Q34485266-1386EBEA-9BF7-4E18-AAB6-C34325838437

P407

Q34485266-412CA450-410A-4D68-A38E-14B0CC5416AD

P433

Q34485266-5839DCEB-E552-4402-9239-33CCA6CA36E3

P478

Q34485266-72F0C526-9EA1-479D-BE25-C2B0696B679A

P577

Q34485266-38B718E6-004C-4E7D-AE86-6C24F8017CBF

P698

Q34485266-71CF7338-2F38-4423-BA65-6C967B4648C8

P921

Q34485266-2A28873B-DC4D-49C2-B97C-D7A752AE04DA

Q34485266-D9A65E0E-2F7E-4B09-90B2-13DDAE70479E

P932

Q34485266-B0792DEE-4F32-4FEC-AD1A-2FF593298E44

P356

P1433

Journal of Virology

P1476

Norovirus P particle, a novel platform for vaccine development and antibody production.

@en

P2093

Chao Wei

http://www.w3.org/2001/XMLSchema#string

Ming Tan

http://www.w3.org/2001/XMLSchema#string

Ming Xia

http://www.w3.org/2001/XMLSchema#string

Monica McNeal

http://www.w3.org/2001/XMLSchema#string

Pengwei Huang

http://www.w3.org/2001/XMLSchema#string

Ping-An Fang

http://www.w3.org/2001/XMLSchema#string

Weiming Zhong

http://www.w3.org/2001/XMLSchema#string

Wen Jiang

http://www.w3.org/2001/XMLSchema#string

Xi Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors

Structural basis for the recognition of blood group trisaccharides by norovirus

X-ray crystallographic structure of the Norwalk virus capsid

Crystal structure of Thermotoga maritima alpha-L-fucosidase. Insights into the catalytic mechanism and the molecular basis for fucosidosis

Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*)

UCSF Chimera--a visualization system for exploratory research and analysis

EMAN: semiautomated software for high-resolution single-particle reconstructions

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

Antibody-dependent and -independent protection following intranasal immunization of mice with rotavirus particles

Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns.

P304

753-764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01835-10

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21068235

http://www.w3.org/2001/XMLSchema#string

P921

P932

3020015

http://www.w3.org/2001/XMLSchema#string